XX National Congress GIVRE 4-6 April 2019 Rome, Italy
Friday 5th April : IMPLANTS SESSION, STEM CELLS AND GENETICS (17:00-18:30)
PRIMA Clinical Study Update – Dr Yannick Le MER (Paris, France)
2019 KOL Event Meeting on promising results with PRIMA in advanced dry-Age-related Macular Degeneration (AMD) – Short version
Three ophthalmology experts discuss PRIMA in advanced dry-AMD :
- Pr. F. Holz : “Real world unmet medical need : atrophic dry-AMD”
- Pr. D. Palanker : “PRIMA inventor’s motivation”
- Pr. J-A. Sahel : “First in human study PRIMA in AMD”
2019 KOL Event Meeting on promising results with PRIMA in advanced dry-Age-related Macular Degeneration (AMD) – Short version
Highlights
of the KOL meeting : Three ophthalmology experts discuss PRIMA in advanced
dry-AMD :
·
Pr.
F. Holz : “Real world unmet medical need : atrophic dry-AMD”
·
Pr. D. Palanker : “PRIMA inventor’s
motivation”
·
Pr.
J-A. Sahel : “First in human study PRIMA in AMD”
To have access to the Powerpoint presentation, please click on the title
2019 KOL Event Meeting on promising results with PRIMA : Long version
An update
on promising results with PRIMA in advanced dry-Age-related Macular
Degeneration (AMD) presented by three experts and thought leaders in
ophthalmology:
·
Pr.
F. Holz : “Real world unmet medical need : atrophic dry-AMD”
·
Pr. D. Palanker : “PRIMA inventor’s
motivation”
·
Pr.
J-A. Sahel : “First in human study with PRIMA in AMD”
Read the PDF »
2019 KOL Event Meeting on promising results with PRIMA : Long version
An update on promising results with PRIMA in advanced dry-Age-related Macular Degeneration (AMD) presented by three experts and thought leaders in ophthalmology:
- Pr. F. Holz : “Real world unmet medical need : atrophic dry-AMD”
- Pr. D. Palanker : “PRIMA inventor’s motivation”
- Pr. J-A. Sahel : “First in human study with PRIMA in AMD”
Le Point : Disease of the retina: progress in view
Scientific research and high technology now allow the blind and partially sighted to recover some of their lost sense.
In the spotlight. Artificial implants, gene therapy, stem cells, eye transplantation, brain stimulation … Researchers are making great strides towards light.
Acuité AMD: Pixium Vision reveals the results of the study on its subretinal implant
After
announcing in September 2018 the successful activation of its subretinal photovoltaic
implant in 5 French patients with dry AMD, Pixium Vision presented the results
of its feasibility study at a conference in early March.
Dry AMD: “the results of our implant exceed our expectations”
In
September 2018, 5 patients with advanced atrophic dry AMD received the new generation
PRIMA subretinal implant. Six months later, all had preserved their peripheral
vision, and all are able to perceive light signals from central area.
#LetsGoFrance : 19 finalists, 19 talents who will keep France moving in 2019 !
There were 445 entries in the #LetsgoFrance competition, then 64 semi-finalists. Thanks to the votes of PwC’s 5,000 employees, they are now only 19! Revealed this week in Forbes magazine, the 19 finalists of the #LetsgoFrance Trophies are now preparing for the pitch before the Grand Jury.